Crossmark

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Crossref DOI link: https://doi.org/10.1038/s41416-019-0487-5

Published Online: 2019-05-23

Published Print: 2019-07-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Serrano, César

Mariño-Enríquez, Adrián

Tao, Derrick L.

Ketzer, Julia

Eilers, Grant

Zhu, Meijun

Yu, Channing

Mannan, Aristotle M.

Rubin, Brian P.

Demetri, George D.

Raut, Chandrajit P.

Presnell, Ajia

McKinley, Arin

Heinrich, Michael C. https://orcid.org/0000-0003-3790-0478
Czaplinski, Jeffrey T.

Sicinska, Ewa

Bauer, Sebastian

George, Suzanne

Fletcher, Jonathan A.
License Information

Text and Data Mining valid from 2019-05-23

Version of Record valid from 2019-05-23
More Information

Article History

First Online: 23 May 2019

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below